Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReNORM: Biologic Therapy in Severe Asthma Remission
NCT07174713Not yet recruiting
- Sponsor
- Western University
- Start
- Oct 2026
- Primary completion
- Oct 2030
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Open-label trial in asthma (2 arms), sponsored by Western University. Primary endpoints: Extent of imaging-based remission at 2 years, Clinical remission measured by FEV1 and FVC at 2 years and 5 more. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
asthma
Beyond the preview
Go deeper on NCT07174713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07174713.